IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation

被引:677
作者
Hurst, SM
Wilkinson, TS
McLoughlin, RM
Jones, S [1 ]
Horiuchi, S
Yamamoto, N
Rose-John, S
Fuller, GM
Topley, N
Jones, SA [1 ]
机构
[1] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales
[2] Univ Wales Coll Med, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales
[3] Tokyo Med & Dent Univ, Dept Microbiol, Tokyo 113, Japan
[4] Univ Kiel, Kiel Inst Biochem, D-24098 Kiel, Germany
[5] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA
基金
英国医学研究理事会; 英国惠康基金;
关键词
D O I
10.1016/S1074-7613(01)00151-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During acute inflammation, leukocyte recruitment is characterized by an initial infiltration of neutrophils, which are later replaced by a more sustained population of mononuclear cells. Based on both clinical and experimental evidence, we present a role for IL-6 and its soluble receptor (sIL-6R) in controlling this pattern of leukocyte recruitment during peritoneal inflammation. Liberation of sIL-6R from the initial neutrophil infiltrate acts as a regulator of CXC and CC chemokine expression, which contributes to a suppression of neutrophil recruitment and the concurrent attraction of mononuclear leukocytes. Soluble IL-6R-mediated signaling is therefore an important intermediary in the resolution of inflammation and supports transition between the early predominantly neutrophilic stage of an infection and the more sustained mononuclear cell influx.
引用
收藏
页码:705 / 714
页数:10
相关论文
共 37 条
  • [1] Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
    Atreya, R
    Mudter, J
    Finotto, S
    Müllberg, J
    Jostock, T
    Wirtz, S
    Schütz, M
    Bartsch, B
    Holtmann, M
    Becker, C
    Strand, D
    Czaja, J
    Schlaak, JF
    Lehr, HA
    Autschbach, F
    Schürmann, G
    Nishimoto, N
    Yoshizaki, K
    Ito, H
    Kishimoto, T
    Galle, PR
    Rose-John, S
    Neurath, MF
    [J]. NATURE MEDICINE, 2000, 6 (05) : 583 - 588
  • [2] Chemokines and leukocyte traffic
    Baggiolini, M
    [J]. NATURE, 1998, 392 (6676) : 565 - 568
  • [3] PROTECTIVE ROLE OF INTERLEUKIN-6 IN THE LIPOPOLYSACCHARIDE-GALACTOSAMINE SEPTIC SHOCK MODEL
    BARTON, BE
    JACKSON, JV
    [J]. INFECTION AND IMMUNITY, 1993, 61 (04) : 1496 - 1499
  • [4] Bellingan GJ, 1996, J IMMUNOL, V157, P2577
  • [5] Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis
    Brauner, A
    Hylander, B
    Wretlind, B
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) : 402 - 408
  • [6] Desgeorges A, 1997, J RHEUMATOL, V24, P1510
  • [7] Disruption of the cellular inflammatory response to Listeria monocytogenes infection in mice with disruptions in targeted genes
    DiTirro, J
    Rhoades, ER
    Roberts, AD
    Burke, JM
    Mukasa, A
    Cooper, AM
    Frank, AA
    Born, WK
    Orme, IM
    [J]. INFECTION AND IMMUNITY, 1998, 66 (05) : 2284 - 2289
  • [8] A bioactive designer cytokine for human hematopoietic progenitor cell expansion
    Fischer, M
    Goldschmitt, J
    Peschel, C
    Brakenhoff, JPG
    Kallen, KJ
    Wollmer, A
    Grotzinger, J
    RoseJohn, S
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (02) : 142 - 145
  • [9] SOLUBLE INTERLEUKIN-6 RECEPTORS RELEASED FROM T-CELL OR GRANULOCYTE/MACROPHAGE CELL-LINES AND HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS ARE GENERATED THROUGH AN ALTERNATIVE SPLICING MECHANISM
    HORIUCHI, S
    KOYANAGI, Y
    ZHOU, YW
    MIYAMOTO, H
    TANAKA, Y
    WAKI, M
    MATSUMOTO, A
    YAMAMOTO, M
    YAMAMOTO, N
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (08) : 1945 - 1948
  • [10] Horiuchi S, 1998, IMMUNOLOGY, V95, P360, DOI 10.1046/j.1365-2567.1998.00622.x